Events coming soon
Emeryville, CA – November 6, 2018 - 4D Molecular Therapeutics (4DMT), a world-leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product development today announced that company management will participate at the following upcoming investor ...
Emeryville, CA, October 4, 2017 – 4D Molecular Therapeutics announced today that David Kirn, MD, co-founder, Chairman & CEO will present at the annual Partnering Forum, part of the Cell & Gene Meeting on the Mesa to be held October ...
4D Molecular Therapeutics co-founder, Dr. David Schaffer, recently presented an overview of his research entitled “Directed evolution of novel adeno-associated viral vectors for gene therapy” as a contribution to the Henry Stewart Talk Series titled “Gene Transfer and Gene Therapy”, part of ...